Literature DB >> 31845964

Limbic Predominant Age-Related TDP-43 Encephalopathy (LATE): Clinical and Neuropathological Associations.

Lilah M Besser1, Merilee A Teylan2, Peter T Nelson3.   

Abstract

Recently, a consensus working group provided new terminology for a common disease entity, limbic predominant age-related TDP-43 encephalopathy (LATE), and its neuropathological substrate (LATE-NC). LATE-NC not only often co-occurs with Alzheimer disease neuropathological change (ADNC), but also may present in isolation. The present study aimed to investigate potential risk factors and neuropathological characteristics associated with LATE-NC. A sample of 616 autopsied participants (>75 years at death), with TDP-43 immunohistochemical studies performed, was obtained from the National Alzheimer's Coordinating Center. Logistic regression analyses examined associations between demographic, clinical and neuropathological characteristics and LATE-NC (TDP-43 in amygdala, hippocampus, or entorhinal/inferior temporal cortex) (alpha = 0.05). Adjusted models indicated that ADNC, hippocampal sclerosis (HS), arteriolosclerosis, and limbic or amygdala-predominant Lewy body disease (LBD), but not other LBD subtypes, were associated with higher odds of LATE-NC, whereas congestive heart failure (CHF) and motor problems as first predominant symptom were associated with lower odds of LATE-NC. Our findings corroborate previous studies indicating associations between LATE-NC and ADNC, HS, and arteriolosclerosis. Novel findings suggest the association with LATE-NC is restricted to amygdala/limbic-predominant subtype of LBD, and a possible protective (or competing risk) association with CHF. This study may inform future hypothesis-driven research on LATE-NC, a common brain disease of aging.
© 2019 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer; Hippocampus; LATE; Limbic predominant age related TDP-43 encephalopathy; Risk factors; TDP-43

Mesh:

Year:  2020        PMID: 31845964      PMCID: PMC7036651          DOI: 10.1093/jnen/nlz126

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  41 in total

1.  Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.

Authors:  Vanessa D Smith; Adam D Bachstetter; Eseosa Ighodaro; Kelly Roberts; Erin L Abner; David W Fardo; Peter T Nelson
Journal:  Brain Pathol       Date:  2017-03-24       Impact factor: 6.508

2.  Non-Alzheimer's contributions to dementia and cognitive resilience in The 90+ Study.

Authors:  John L Robinson; Maria M Corrada; Gabor G Kovacs; Myrna Dominique; Carrie Caswell; Sharon X Xie; Virginia M-Y Lee; Claudia H Kawas; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2018-06-18       Impact factor: 17.088

3.  Associations of amygdala volume and shape with transactive response DNA-binding protein 43 (TDP-43) pathology in a community cohort of older adults.

Authors:  Nazanin Makkinejad; Julie A Schneider; Junxiao Yu; Sue E Leurgans; Aikaterini Kotrotsou; Arnold M Evia; David A Bennett; Konstantinos Arfanakis
Journal:  Neurobiol Aging       Date:  2019-01-31       Impact factor: 4.673

4.  Hippocampal sclerosis in advanced age: clinical and pathological features.

Authors:  Peter T Nelson; Frederick A Schmitt; Yushun Lin; Erin L Abner; Gregory A Jicha; Ela Patel; Paula C Thomason; Janna H Neltner; Charles D Smith; Karen S Santacruz; Joshua A Sonnen; Leonard W Poon; Marla Gearing; Robert C Green; John L Woodard; Linda J Van Eldik; Richard J Kryscio
Journal:  Brain       Date:  2011-05       Impact factor: 13.501

5.  Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains.

Authors:  Keith A Josephs; Melissa E Murray; Nirubol Tosakulwong; Stephen D Weigand; Amanda M Serie; Ralph B Perkerson; Billie J Matchett; Clifford R Jack; David S Knopman; Ronald C Petersen; Joseph E Parisi; Leonard Petrucelli; Matthew Baker; Rosa Rademakers; Jennifer L Whitwell; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2019-01-02       Impact factor: 17.088

6.  TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.

Authors:  Bryan D James; Robert S Wilson; Patricia A Boyle; John Q Trojanowski; David A Bennett; Julie A Schneider
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

7.  Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons.

Authors:  Peter T Nelson; Erin L Abner; Frederick A Schmitt; Richard J Kryscio; Gregory A Jicha; Charles D Smith; Daron G Davis; John W Poduska; Ela Patel; Marta S Mendiondo; William R Markesbery
Journal:  Brain Pathol       Date:  2008-11-19       Impact factor: 6.508

8.  Primary age-related tauopathy (PART): a common pathology associated with human aging.

Authors:  John F Crary; John Q Trojanowski; Julie A Schneider; Jose F Abisambra; Erin L Abner; Irina Alafuzoff; Steven E Arnold; Johannes Attems; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Dennis W Dickson; Marla Gearing; Lea T Grinberg; Patrick R Hof; Bradley T Hyman; Kurt Jellinger; Gregory A Jicha; Gabor G Kovacs; David S Knopman; Julia Kofler; Walter A Kukull; Ian R Mackenzie; Eliezer Masliah; Ann McKee; Thomas J Montine; Melissa E Murray; Janna H Neltner; Ismael Santa-Maria; William W Seeley; Alberto Serrano-Pozo; Michael L Shelanski; Thor Stein; Masaki Takao; Dietmar R Thal; Jonathan B Toledo; Juan C Troncoso; Jean Paul Vonsattel; Charles L White; Thomas Wisniewski; Randall L Woltjer; Masahito Yamada; Peter T Nelson
Journal:  Acta Neuropathol       Date:  2014-10-28       Impact factor: 17.088

9.  Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.

Authors:  Peter T Nelson; Dennis W Dickson; John Q Trojanowski; Clifford R Jack; Patricia A Boyle; Konstantinos Arfanakis; Rosa Rademakers; Irina Alafuzoff; Johannes Attems; Carol Brayne; Ian T S Coyle-Gilchrist; Helena C Chui; David W Fardo; Margaret E Flanagan; Glenda Halliday; Suvi R K Hokkanen; Sally Hunter; Gregory A Jicha; Yuriko Katsumata; Claudia H Kawas; C Dirk Keene; Gabor G Kovacs; Walter A Kukull; Allan I Levey; Nazanin Makkinejad; Thomas J Montine; Shigeo Murayama; Melissa E Murray; Sukriti Nag; Robert A Rissman; William W Seeley; Reisa A Sperling; Charles L White; Lei Yu; Julie A Schneider
Journal:  Brain       Date:  2019-06-01       Impact factor: 15.255

Review 10.  Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set.

Authors:  Lilah Besser; Walter Kukull; David S Knopman; Helena Chui; Douglas Galasko; Sandra Weintraub; Gregory Jicha; Cynthia Carlsson; Jeffrey Burns; Joseph Quinn; Robert A Sweet; Katya Rascovsky; Merilee Teylan; Duane Beekly; George Thomas; Mark Bollenbeck; Sarah Monsell; Charles Mock; Xiao Hua Zhou; Nicole Thomas; Elizabeth Robichaud; Margaret Dean; Janene Hubbard; Mary Jacka; Kristen Schwabe-Fry; Joylee Wu; Creighton Phelps; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Oct-Dec       Impact factor: 2.703

View more
  20 in total

1.  Novel monoclonal antibodies targeting the RRM2 domain of human TDP-43 protein.

Authors:  Jorge A Trejo-Lopez; Zachary A Sorrentino; Cara J Riffe; Grace M Lloyd; Sydney A Labuzan; Dennis W Dickson; Anthony T Yachnis; Stefan Prokop; Benoit I Giasson
Journal:  Neurosci Lett       Date:  2020-09-06       Impact factor: 3.046

Review 2.  Recent update on the heterogeneity of the Alzheimer's disease spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-12-17       Impact factor: 3.575

3.  Limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) is independently associated with dementia and strongly associated with arteriolosclerosis in the oldest-old.

Authors:  William T Harrison; Jay B Lusk; Beiyu Liu; John F Ervin; Kim G Johnson; Cynthia L Green; Shih-Hsiu J Wang
Journal:  Acta Neuropathol       Date:  2021-08-20       Impact factor: 17.088

4.  Differences in Symptomatic Presentation and Cognitive Performance Among Participants With LATE-NC Compared to FTLD-TDP.

Authors:  Merilee A Teylan; Charles Mock; Kathryn Gauthreaux; Jessica E Culhane; Gregory Jicha; Yen-Chi Chen; Kwun C G Chan; Walter A Kukull; Peter T Nelson; Yuriko Katsumata
Journal:  J Neuropathol Exp Neurol       Date:  2021-10-01       Impact factor: 3.685

Review 5.  Limbic-Predominant Age-Related TDP-43 Encephalopathy: LATE-Breaking Updates in Clinicopathologic Features and Biomarkers.

Authors:  Michael Tran Duong; David A Wolk
Journal:  Curr Neurol Neurosci Rep       Date:  2022-10-03       Impact factor: 6.030

Review 6.  Heterogeneity in Alzheimer's Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials.

Authors:  Ranjan Duara; Warren Barker
Journal:  Neurotherapeutics       Date:  2022-01-27       Impact factor: 6.088

Review 7.  Neuropathological assessment of the Alzheimer spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2020-08-01       Impact factor: 3.575

8.  Alzheimer's Disease Neuropathological Comorbidities are Common in the Younger-Old.

Authors:  Thomas G Beach; Michael Malek-Ahmadi
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

9.  Association of Hemoglobin A1C With TDP-43 Pathology in Community-Based Elders.

Authors:  Shahram Oveisgharan; Ana W Capuano; Sukriti Nag; Sonal Agrawal; Lisa L Barnes; David A Bennett; Zoe Arvanitakis; Julie A Schneider
Journal:  Neurology       Date:  2021-04-14       Impact factor: 11.800

Review 10.  Impact of Cardiovascular Hemodynamics on Cognitive Aging.

Authors:  Elizabeth E Moore; Angela L Jefferson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-02-11       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.